Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-000499

MELINTA THERAPEUTICS, INC. /NEW/ · MLNT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
David N Gill
Director
Period of report
Jan 3, 2016
Accepted (ET)
Jan 4, 2017 · 7:46 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001461993

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJan 3, 2017P5,000$2.944A5,000D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F1$23.51holding————Dec 31, 2024Common Stock15,00015,000D
Stock Option (Right to Buy)F2$7.55holding————Apr 1, 2022Common Stock25,00025,000D
Stock Option (Right to Buy)F3$6.79holding————Feb 3, 2023Common Stock15,00015,000D
Stock Option (Right to Buy)F4$13.10holding————Jan 7, 2024Common Stock15,00015,000D
Stock Option (Right to Buy)F5$31.13holding————Dec 31, 2025Common Stock15,00015,000D

Explanation of responses